UCB stock is currently trading around $35, reflecting a 6% rise post-earnings due to strong Q4 results, including a net income surge to $75.8M and EPS of $0.61, beating estimates. Bulls highlight the company's robust revenue growth (+44.5% YoY) and strategic acquisitions like ANB Holdings, which could enhance future earnings potential. Piper Sandler's raised price target to $35 aligns with the current valuation, suggesting limited immediate upside.